|
|
News Breaks | | | | December 10, 2012 | | 08:05 EDT |  | TSRX | Trius Therapeutics completes enrollment of second Phase 3 trial of Tedizolid
Trius Therapeutics announced that it has reached its enrollment objective of 658 patients in the last of its two Phase 3 clinical trials of tedizolid phosphate, or TR-701, for the treatment of acute bacterial skin and skin structure infections. The pivotal Phase 3 trial, designated ESTABLISH 2, examines the efficacy and safety of a six-day course of tedizolid administered once a day versus a 10-day course of linezolid, or Zyvox, administered twice a day in patients recruited across sites in North and South America, Europe, Australia, New Zealand and South Africa. For both tedizolid phosphate and linezolid, drug was initially administered as an intravenous infusion with the option to switch to oral therapy after the initial day of therapy. | |
|
News For TSRX From The Last 14 Days Check below for free stories on TSRX the last two weeks. |
|
|
| May 13, 2013 | | 08:18 EDT | | TSRX | Trius Therapeutics annoucnes notice of patent applications
 Subscribe for More Information | | | May 10, 2013 | | 10:00 EDT |  | TSRX | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. | | | 07:25 EDT | | TSRX | Trius Therapeutics initiated with a Buy at Guggenheim
Subscribe for More Information | |
|
|
|
|
|
|
